Mark Eisner
Director/Board Member chez The Genentech Foundation
Fortune : 375 805 $ au 31/03/2024
Profil
Le Dr Mark Eisner, MD, est médecin en chef chez FibroGen, Inc. Le Dr. Eisner était auparavant employé en tant que vice-président senior par Genentech, Inc. et professeur à l'Université de Californie, San Francisco. Il a obtenu son diplôme de premier cycle à l'Université de Stanford, un doctorat à l'École de santé publique de l'UC Berkeley et un doctorat au Centre médical de l'Université de Pennsylvanie.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FIBROGEN, INC.
0,16% | 06/09/2023 | 159 917 ( 0,16% ) | 375 805 $ | 31/03/2024 |
Postes actifs de Mark Eisner
| Sociétés | Poste | Début |
|---|---|---|
| The Genentech Foundation | Director/Board Member | - |
Anciens postes connus de Mark Eisner
| Sociétés | Poste | Fin |
|---|---|---|
| FIBROGEN, INC. | Chief Tech/Sci/R&D Officer | 08/09/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| The University of California, San Francisco | Corporate Officer/Principal | - |
Formation de Mark Eisner
| Stanford University | Undergraduate Degree |
| UC Berkeley School of Public Health | Doctorate Degree |
| University of Pennsylvania Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| The Genentech Foundation | Miscellaneous |
